European OTC Results Round-Up: Boiron, Alliance Pharma and Karo
Executive Summary
COVID-19 had a differing impact on Q2 consumer health sales for France's Boiron, the UK's Alliance Pharma and Sweden's Karo.
You may also be interested in...
EU Business Round-Up: Galenica Acquires Spagyros, Karo Offloads OTCs, And Ceres Gets New Owners
The latest European business news: Galenica strengthens its porfolio in Switzerland with Spagyros; Sweden's Karo offloads OTCs to Evolan; and Ceres Pharma sold to French private-equity firm.
France's Boiron Diversifies Into Probiotics To Arrest Sales Decline
Homeopathy specialist Boiron its diversifying its offering into the increasingly popular probiotics segment with launches underway in France, Italy and Spain, as well as Eastern Europe.
Alliance Pharma Targeting M&A To Grow OTC Portfolio
UK-based Alliance Pharma is currently looking at deals - large and small - to expand its consumer health portfolio in its existing markets, including the US and Europe.